Characterization and autoregulation of latent transforming growth factor beta (TGF beta) complexes in osteoblast-like cell lines. Production of a latent complex lacking the latent TGF beta-binding protein
- PMID: 8120044
Characterization and autoregulation of latent transforming growth factor beta (TGF beta) complexes in osteoblast-like cell lines. Production of a latent complex lacking the latent TGF beta-binding protein
Abstract
We have previously shown that bone organ cultures produce large amounts of latent transforming growth factor beta (TGF beta), which lacks latent TGF beta-binding protein (LTBP). In this study we used the known osteoblast-like cell lines UMR-106, ROS 17/2.8, and MG63 as models to further examine latent TGF beta expression in bone. We found that the osteosarcoma cell line UMR-106 secreted latent TGF beta almost exclusively as a 100-kDa complex lacking LTBP. ROS 17/2.8 cells produced both the 100-kDa complex and also a 290-kDa complex containing the fibroblastic (190 kDa) form of LTBP. MG63 cells (like human foreskin fibroblasts) expressed almost exclusively the 290-kDa complex. To investigate the regulation of latent TGF beta complexes in bone cells we assessed the effects of TGF beta 1 treatment on expression of active and latent TGF beta. TGF beta 1 induced secretion of latent but not active TGF beta in all cell types examined. In human foreskin fibroblast cells, TGF beta 1 and LTBP mRNA were expressed concomitantly. In contrast, in osteosarcoma cell lines autoinduction of TGF beta 1 mRNA was associated with either a delayed increase or no change in LTBP mRNA. In UMR-106 cells LTBP message was virtually undetectable. We postulate that the expression of different latent TGF beta forms by osteoblast-like cells may reflect their maturation states and that different latent TGF beta complexes may have different functions, for example as secretory forms or as matrix storage forms.
Similar articles
-
Parathyroid hormone stimulation and PKA signaling of latent transforming growth factor-beta binding protein-1 (LTBP-1) mRNA expression in osteoblastic cells.J Cell Biochem. 2005 Aug 1;95(5):1002-11. doi: 10.1002/jcb.20453. J Cell Biochem. 2005. PMID: 15880704
-
Latent transforming growth factor-beta complex in Chinese hamster ovary cells contains the multifunctional cysteine-rich fibroblast growth factor receptor, also termed E-selectin-ligand or MG-160.Biochem J. 1997 Jun 1;324 ( Pt 2)(Pt 2):427-34. doi: 10.1042/bj3240427. Biochem J. 1997. PMID: 9182700 Free PMC article.
-
Novel non-TGF-beta-binding splice variant of LTBP-4 in human cells and tissues provides means to decrease TGF-beta deposition.J Cell Sci. 2001 Aug;114(Pt 15):2869-78. doi: 10.1242/jcs.114.15.2869. J Cell Sci. 2001. PMID: 11683420
-
Latent transforming growth factor-beta binding proteins (LTBPs)--structural extracellular matrix proteins for targeting TGF-beta action.Cytokine Growth Factor Rev. 1999 Jun;10(2):99-117. doi: 10.1016/s1359-6101(99)00010-6. Cytokine Growth Factor Rev. 1999. PMID: 10743502 Review.
-
Latency, activation, and binding proteins of TGF-beta.Microsc Res Tech. 2001 Feb 15;52(4):354-62. doi: 10.1002/1097-0029(20010215)52:4<354::AID-JEMT1020>3.0.CO;2-G. Microsc Res Tech. 2001. PMID: 11170294 Review.
Cited by
-
Liver portal fibrosis in dioxin receptor-null mice that overexpress the latent transforming growth factor-beta-binding protein-1.Int J Exp Pathol. 2004 Oct;85(5):295-302. doi: 10.1111/j.0959-9673.2004.00397.x. Int J Exp Pathol. 2004. PMID: 15379962 Free PMC article.
-
E-selectin ligand 1 regulates bone remodeling by limiting bioactive TGF-β in the bone microenvironment.Proc Natl Acad Sci U S A. 2013 Apr 30;110(18):7336-41. doi: 10.1073/pnas.1219748110. Epub 2013 Apr 15. Proc Natl Acad Sci U S A. 2013. PMID: 23589896 Free PMC article.
-
Integrin alpha(v)beta8-mediated activation of transforming growth factor-beta by perivascular astrocytes: an angiogenic control switch.Am J Pathol. 2005 Jun;166(6):1883-94. doi: 10.1016/s0002-9440(10)62497-2. Am J Pathol. 2005. PMID: 15920172 Free PMC article.
-
Insulin impedes osteogenesis of BMSCs by inhibiting autophagy and promoting premature senescence via the TGF-β1 pathway.Aging (Albany NY). 2020 Feb 3;12(3):2084-2100. doi: 10.18632/aging.102723. Epub 2020 Feb 3. Aging (Albany NY). 2020. PMID: 32017705 Free PMC article.
-
Excessive transforming growth factor-β signaling is a common mechanism in osteogenesis imperfecta.Nat Med. 2014 Jun;20(6):670-5. doi: 10.1038/nm.3544. Epub 2014 May 4. Nat Med. 2014. PMID: 24793237 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials